Processa Pharmaceuticals, Inc. Property, Plant and Equipment, Gross
Processa Pharmaceuticals, Inc. (PCSA) had Property, Plant and Equipment, Gross of $29.07 thousand as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2022-03-30
- 2021-12-31: Property, Plant and Equipment, Gross $29.07K.
- 2021-09-30: Property, Plant and Equipment, Gross $29.07K.
- 2021-06-30: Property, Plant and Equipment, Gross $29.07K.
- 2021-03-31: Property, Plant and Equipment, Gross $29.07K.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2021-12-31 | $29.07K 10-K · filed 2022-03-30 | |
| 2021-09-30 | $29.07K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $29.07K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $29.07K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $29.07K 10-K · filed 2022-03-30 | |
| 2020-03-31 | $29.07K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $29.07K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $29.07K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $29.07K 10-Q · filed 2019-08-14 | |
| 2018-12-31 | $29.07K 10-K · filed 2020-03-06 | |
| 2018-09-30 | $29.07K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $29.07K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $29.07K 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $29.07K 10-Q · filed 2018-11-14 | |
| 2016-12-31 | $23.77K 10-K · filed 2018-04-16 | |
| 2015-12-31 | $19.15K 10-K · filed 2017-06-19 | |
| 2015-09-30 | $347.80K 10-Q · filed 2015-12-01 | |
| 2015-06-30 | $641.99K 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $653.56K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $507.11K 10-K · filed 2017-06-19 | $652.16K 10-K · filed 2015-04-14 |
| 2014-09-30 | $629.58K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $570.43K 10-Q · filed 2014-08-19 | |
| 2014-03-31 | $568.43K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $446.90K 10-K · filed 2015-04-14 | |
| 2013-09-30 | $446.90K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $343.05K 10-Q/A · filed 2013-09-06 | |
| 2012-12-31 | $335.72K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |